Microbot Medical Inc Share Price Nasdaq
Equities
US59503A1051
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.39M 1.12B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.32% |
Managers | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02/88/02 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01/22/01 |
Chief Tech/Sci/R&D Officer | - | 01/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28/16/28 |
Director/Board Member | 66 | 12/17/12 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01/20/01 |
1st Jan change | Capi. | |
---|---|---|
+33.36% | 49.46B | |
+1.65% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.53% | 26.61B | |
-22.68% | 18.64B | |
+8.13% | 13.16B | |
+29.14% | 12.55B | |
+24.25% | 12.1B |